NCT04810637View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19

PHASE2UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

September 30, 2021

Conditions
Covid19
Interventions
DRUG

GX-I7

Recombinant human interleukin-7 hybrid Fc

Trial Locations (2)

Unknown

RECRUITING

Mitra Keluarga Kelapa Gading, Jakarta Pusat

RECRUITING

Mitra Keluarga Kemayoran, Jakarta Pusat

Sponsors

Collaborators (1)

Genexine, Inc.
All Listed Sponsors
collaborator

Genexine, Inc.

INDUSTRY

lead

PT Kalbe Genexine Biologics

INDUSTRY

NCT04810637 - A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19 | Biotech Hunter | Biotech Hunter